Date Title Description PDF
26 Jul 2023 On P&L The Company releases the press release related to the first half 2023 financial results Download
26 Jul 2023 On P&L The Company releases the first half 2023 financial results presentation Download
26 Jul 2023 On buy-back programmes The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.   Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download

Pages

Date Title Description PDF
05 Nov 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted on 3 and 4 November Download
03 Nov 2021 On business and financial situation The Company releases the first nine months 2021 financial results presentation Download
03 Nov 2021 On business and financial situation The Company releases the press release related to the first nine months 2021 financial results Download
21 Oct 2021 Liquidity and counterparty agreements Download
21 Oct 2021 On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Download

Pages

Date Title Description PDF
20 Feb 2018 Información sobre resultados ROVI releases the presentation related to the full year 2017 results Download
20 Feb 2018 Información sobre resultados ROVI releases the press release related to the full year 2017 results Download
20 Feb 2018 Informe anual de remuneraciones de los consejeros ROVI releases the 2017 annual report regarding remuneration of the members of the Board of Directors Download
20 Feb 2018 Informe Anual de Gobierno Corporativo ROVI releases the 2017 Annual Corporate Governance Report Download
20 Feb 2018 Otros sobre gobierno corporativo The Company informs about the agreements adopted by the Board of Directors Download

Pages